Anthony S. Fiorino serves as Executive at BRAINSTORM CELL THERAPEUTICS INC., where they oversee executive responsibilities. Since joining the company, Anthony S. Fiorino has executed 12 insider transactions totaling $29.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 3, 2020 involved selling 75,000 shares valued at $0.
Anthony S. Fiorino currently holds 75,000 shares of BRAINSTORM CELL THERAPEUTICS INC. (BCLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Anthony S. Fiorino has been a net buyer of BCLI stock. They have purchased $29.0K and sold $0 worth of shares.
Anthony S. Fiorino's most recent insider trade was on Feb 3, 2020, when they sold 75,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.24 |
| Discretionary |
| May 17, 2018 | IMNP | $13.0K | Purchase | 50,000 | $0.26 | Discretionary |
| Jun 30, 2017 | NAVB | $0 | Award | 50,000 | $N/A | Discretionary |
| Apr 20, 2016 | NAVB | $0 | Award | 28,000 | $N/A | Discretionary |
| Oct 15, 2014 | BCLI | $718 | Purchase | 200 | $3.59 | Discretionary |
| Oct 15, 2014 | BCLI | $1.1K | Purchase | 300 | $3.60 | Discretionary |
| Sep 18, 2014 | BCLI | $3.1K | Purchase | 800 | $3.84 | Discretionary |
| Sep 15, 2014 | BCLI | $1.4K | Purchase | 5,000 | $0.29 | Discretionary |
| Sep 15, 2014 | BCLI | $840 | Purchase | 3,000 | $0.28 | Discretionary |
| Sep 12, 2014 | BCLI | $700 | Purchase | 2,500 | $0.28 | Discretionary |
| Sep 12, 2014 | BCLI | $2.2K | Purchase | 7,500 | $0.29 | Discretionary |